儿童过敏性紫癜凝血纤溶系统变化与肾损伤的相关性分析(4)
[11]Matsuo T,Kobayashi H,Kario K,et al.Fibrin D-dimer in thrombogenic disorders[J].Semin Thromb Hemost,2000,26(1):101-107.
[12]Wang F,Huang L,Tang H,et al.Significance of glomerular fibrinogen deposition in children with henoch-sch■nlein purpura nephritis[J].Ital J Pediatr,2018,44(1):97.
[13]Tian M,Liu C.Heparin calcium treated henoch-sch■nlein purpura nephritis in children through inhibiting hyperfibrinolysis[J].Ren Fail,2015,37(7):1100-1104.
[14]朱廷富,褚祝飞,李精华.雷公藤多苷联合丹参注射液对过敏性紫癜性肾炎患儿凝血机制的影响[J].中国中药杂志,2016,41(11):2162-2167.
[15]Shao WX,Ye Q,Wang XJ.Application value of laboratory indexes in the differential diagnosis of henoch-sch■enlein purpura[J].Z Rheumatol,2017,76(4):351-356.
[16]Ge W,Wang HL,Sun RP.Pentraxin 3 as a novel early biomarker for the prediction of henoch-sch■nlein purpura nephritis in children[J].Eur J Pediatr,2014,173(2):213-218.
[17]赵红,窦志艳,李玉秋.中西医结合治疗对儿童过敏性紫癜肾损害的预防作用[J].中国中西医结合杂志,2009,29(4):351-353.
(收稿日期:2019-06-26 本文編辑:刘克明), 百拇医药(江雄 冯战桂 袁科龙)
[12]Wang F,Huang L,Tang H,et al.Significance of glomerular fibrinogen deposition in children with henoch-sch■nlein purpura nephritis[J].Ital J Pediatr,2018,44(1):97.
[13]Tian M,Liu C.Heparin calcium treated henoch-sch■nlein purpura nephritis in children through inhibiting hyperfibrinolysis[J].Ren Fail,2015,37(7):1100-1104.
[14]朱廷富,褚祝飞,李精华.雷公藤多苷联合丹参注射液对过敏性紫癜性肾炎患儿凝血机制的影响[J].中国中药杂志,2016,41(11):2162-2167.
[15]Shao WX,Ye Q,Wang XJ.Application value of laboratory indexes in the differential diagnosis of henoch-sch■enlein purpura[J].Z Rheumatol,2017,76(4):351-356.
[16]Ge W,Wang HL,Sun RP.Pentraxin 3 as a novel early biomarker for the prediction of henoch-sch■nlein purpura nephritis in children[J].Eur J Pediatr,2014,173(2):213-218.
[17]赵红,窦志艳,李玉秋.中西医结合治疗对儿童过敏性紫癜肾损害的预防作用[J].中国中西医结合杂志,2009,29(4):351-353.
(收稿日期:2019-06-26 本文編辑:刘克明), 百拇医药(江雄 冯战桂 袁科龙)